Alfileramine



Compound IDCDAMM02417
Common nameAlfileramine
IUPAC name4-[2-(dimethylamino)ethyl]-2-[2-[2-(dimethylamino)ethyl]-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-7-yl]phenol
Molecular formulaC30H42N2O2

Experimental data

Retention time11.02
Adduct[M+H]+
Actual mz463.331
Theoretical mz463.332
Error2.11
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.2098

Identifiers and class information

Inchi keyGKQFYWMPBGPDAW-ZESYGTMMNA-N
SmilesOC1=CC=C(C=C1C2C=C(C)CC3C4=CC(=CC=C4OC(C)(C)C23)CCN(C)C)CCN(C)C
SuperclassOrganoheterocyclic compounds
ClassBenzopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)2
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)1
Molecular weight (mol_MW)462.674
Computed dipole moment(dipole)2.393
Total solvent accessible surface area (SASA)872.904
Hydrophobic component of SASA (FOSA)642.221
Hydrophilic component of SASA (FISA)49.853
Pie component of the SASA (PISA)180.831
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1614.64
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0035467
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0063008
Globularity descriptor (glob)0.762515
Predicted polarizability in cubic angstroms (QPpolrz)55.696
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.323
Predicted octanol/gas partition coefficient (QPlogPoct)22.416
Predicted water/gas partition coefficient (QPlogPw)8.727
Predicted octanol/water partition coefficient (QPlogPo/w)5.943
Predicted aqueous solubility (QPlogS)-6.529
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.212
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-7.689
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)207.466
Predicted brain/blood partition coefficient (QPlogBB)0.367
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)110.614
Predicted skin permeability, log Kp (QPlogKp)-5.254
PM3 calculated ionization potential (IP(ev))8.756
PM3 calculated electron affinity (EA(eV))-0.202
Number of likely metabolic reactions (#metab)11
Prediction of binding to human serum albumin (QPlogKhsa)1.625
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)90.252
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)39.26
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P21554CNR1Cannabinoid receptor 1 (by homology)T76685SEA
P34972CNR2Cannabinoid receptor 2T37693SEA
Q14330GPR18N-arachidonyl glycine receptorT72267SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T76685DI0031Anorexia nervosa[ICD-11: 6B80]P21554CNR1
T76685DI0214Insomnia[ICD-11: 7A00-7A0Z]P21554CNR1
T76685DI0308Obesity[ICD-11: 5B80-5B81]P21554CNR1
T37693DI0040Attention deficit hyperactivity disorder[ICD-11: 6A05]P34972CNR2
T37693DI0214Insomnia[ICD-11: 7A00-7A0Z]P34972CNR2

Copyright © 2025